Unlisted
| Company Name | 주식회사 펨토바이오메드 |
| English Name | Femtobiomed Inc. |
| Business Reg. No. | 5068176351 |
| CEO | 이상현 (단독대표) |
| Address | 경기도 성남시 분당구 판교로 700D동 510호(야탑동, 분당테크노파크) |
| Industry | 그 외 기타 의료용 기기 제조업 |
| Industry Code | 271 |
| Main Products | 의료기기(접촉각 측정장치) 제조/CellShot 플랫폼 / CellShot 기반 항암백신치료 제품군 / CellShot 기반 자가면역질환치료 제품군 / CellShot 기반 바이오의약 |
| Established | 20110708 |
| Phone | 031-622-8501 |
| Website | www.femtobiomed.com |
| Regular Employees | 15persons |
| Corp. Reg. No. | 1717110094696 |
Venture Certified
| 기술평가보증기업(기금) | 2012-03-22 ~ 2014-03-21 | 20120201027 | 2012-03-22 |
| 기술평가대출기업(중진공) | 2014-03-22 ~ 2016-03-21 | 20140400235 | 2012-03-22 |
| 벤처투자유형 | 2016-09-13 ~ 2018-09-12 | 20160300439 | 2012-03-22 |
| 벤처투자유형 | 2018-09-13 ~ 2020-09-12 | 20180300676 | 2012-03-22 |
| 벤처투자유형 | 2020-09-13 ~ 2022-09-12 | 20200301109 | 2012-03-22 |
| 벤처투자유형 | 2022-09-13 ~ 2025-09-12 | 20220824010010 | 2012-03-22 |
| 벤처투자유형 | 2025-09-13 ~ 2028-09-12 | 20250806010005 | 2012-03-22 |
Revenue CAGR -6.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1.6B | 3.3B | 1.8B |
| Operating Profit | -53B | -35B | -57B |
| Net Profit | -49B | -22B | -12B |
| Total Assets | 35B | 33B | 41B |
| Total Liabilities | 147B | 121B | 113B |
| Total Equity | -111B | -89B | -72B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -53B
Revenue down 52% YoY
3 Consecutive Years of Net Loss
▼ 38.5%
▼ 14.8%
▼ 60.1%
▲ 10.1%
▲ 109.8%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 이상현 | 사내이사 | 기술 총괄 | - |
| 박준권 | 사내이사 | 연구 총괄 | - |
| 심재승 | 감사 | 감사 | - |
| 정완균 | 사외이사 | 사외 이사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 17persons |
| CEO | 이상현 (단독대표) |
| Est. Avg. Annual Salary | 5,64110K (47010K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2012-01-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "경기도 성남시 분당구 판교로",
"brno": "506817****",
"cappedWarning": false,
"companyName": "주식회사 펨토바이오메드",
"estimatedAvgAnnualSalary": 56406840,
"estimatedAvgMonthlySalary": 4700570,
"fetchedAt": "2026-03-05T11:12:43.869Z",
"industryCode": "331201",
"industryName": "물질 검사, 측정 및 분석 기구 제조업",
"joinDate": "20120101",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 7591420,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6425170",
"status": "1",
"styleCode": "1",
"subscriberCount": 17,
"turnoverMonths": 1
}{
"address": "경기 성남시",
"ceo_name": "이상현",
"certificate": [
{
"cert_number": "20120201027",
"changes": "",
"disclosure_date": "2012-03-22",
"first_cert_date": "2012-03-22",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-03-22 ~ 2014-03-21"
},
{
"cert_number": "20140400235",
"changes": "",
"disclosure_date": "2014-03-26",
"first_cert_date": "2012-03-22",
"no": "2",
"type": "기술평가대출기업(중진공)",
"valid_period": "2014-03-22 ~ 2016-03-21"
},
{
"cert_number": "20160300439",
"changes": "",
"disclosure_date": "2016-09-13",
"first_cert_date": "2012-03-22",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2016-09-13 ~ 2018-09-12"
},
{
"cert_number": "20180300676",
"changes": "",
"disclosure_date": "2018-10-11",
"first_cert_date": "2012-03-22",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2018-09-13 ~ 2020-09-12"
},
{
"cert_number": "20200301109",
"changes": "",
"disclosure_date": "2020-09-24",
"first_cert_date": "2012-03-22",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2020-09-13 ~ 2022-09-12"
},
{
"cert_number": "20220824010010",
"changes": "",
"disclosure_date": "2022-08-24",
"first_cert_date": "2012-03-22",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2022-09-13 ~ 2025-09-12"
},
{
"cert_number": "20250806010005",
"changes": "",
"disclosure_date": "2025-08-06",
"first_cert_date": "2012-03-22",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2025-09-13 ~ 2028-09-12"
}
],
"company_name": "주식회사 펨토바이오메드",
"corp_no": "171711-*******",
"financials": {
"2022": {
"capital_stock": 4200636000,
"cost_of_sales": 120409000,
"current_assets": 2352354000,
"current_liabilities": 11105096000,
"gross_profit": 62962000,
"net_income": -1225297000,
"net_income_bs": -1225297000,
"non_current_assets": 1719050000,
"non_current_liabilities": 193769000,
"non_operating_expenses": 253515000,
"non_operating_income": 4746341000,
"operating_profit": -5718123000,
"revenue": 183372000,
"sga_expenses": 5781085000,
"total_assets": 4071404000,
"total_equity": -7227460000,
"total_liabilities": 11298865000
},
"2023": {
"capital_stock": 4200636000,
"cost_of_sales": 125449000,
"current_assets": 2093986000,
"current_liabilities": 11987741000,
"gross_profit": 208505000,
"net_income": -2248525000,
"net_income_bs": -2248524000,
"non_current_assets": 1193207000,
"non_current_liabilities": 156399000,
"non_operating_expenses": 396889000,
"non_operating_income": 1698308000,
"operating_profit": -3549944000,
"revenue": 333954000,
"sga_expenses": 3758449000,
"total_assets": 3287193000,
"total_equity": -8856947000,
"total_liabilities": 12144140000
},
"2024": {
"capital_stock": 4220858000,
"cost_of_sales": 97688000,
"current_assets": 2876181000,
"current_liabilities": 14608971000,
"gross_profit": 61327000,
"net_income": -4943358000,
"net_income_bs": -4943358000,
"non_current_assets": 672485000,
"non_current_liabilities": 71851000,
"non_operating_expenses": 537079000,
"non_operating_income": 915700000,
"operating_profit": -5321979000,
"revenue": 159015000,
"sga_expenses": 5383306000,
"total_assets": 3548666000,
"total_equity": -11132155000,
"total_liabilities": 14680822000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [
{
"amount": "2,999,996,625",
"changes": "2,999,996,625",
"date": "2024-04-23"
},
{
"amount": "4,999,000,000",
"changes": "4,999,000,000",
"date": "2021-02-26"
},
{
"amount": "999,000,000",
"changes": "999,000,000",
"date": "2021-02-26"
},
{
"amount": "1,498,680,000",
"changes": "1,498,680,000",
"date": "2016-01-13"
}
],
"main_products": "의료기기(접촉각 측정장치) 제조/CellShot 플랫폼 / CellShot 기반 항암백신치료 제품군 / CellShot 기반 자가면역질환치료 제품군 / CellShot 기반 바이오의약",
"phone": "031-628-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |